Abstract
Lung cancer is one of the deadliest cancers worldwide. It can be divided into lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC). Cytochrome P450 Family 4 Subfamily B Member 1 (CYP4B1) is primarily expressed in the lung. We have previously shown that higher CPY4B1 expression is correlated with better survival and a less immunosuppressive microenvironment in LUAD. However, the role of CYP4B1 in LUSC is still unknown. Thus, we analyzed the prognostic value of CYP4B1 and its association with the tumor immune microenvironment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
